Back to Authors

Marjanovic, Dragan

0000-0001-9967-7828

Mayo Clinic

Danish Epilepsy Center, Filadelfia, 4293 Dianalund, Denmark.

Citations 1

4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2 -encephalopathy

Science Translational Medicine | September 2, 2021 | Volume: 13 | Issue: 609 | Pages: No page available

10.1126/scitranslmed.aaz4957 | PMID 34516822

4-Aminopyridine is a potential therapeutic option for a subgroup of patients with KCNA2 -encephalopathy and gain-of-function variants.